STAT3d
After a rocky debut for new RSV tools, hopes are high as a new season approaches
Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...
GSK’s ex-vaccines chief says its jab for a flu-like virus is too expensive
GSK’s ex-head of vaccines says its blockbuster jab for a flu-like virus that spreads in the autumn and winter is too ...
Making an RSV Vaccine Was Hard. Getting People to Take It Is Even Harder
RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are ...
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst said, and could mean weak earnings for ...
BioSpace18d
GSK Builds Combo Case for RSV, Shingles Shots With Phase III Data
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...
pharmaphorum17d
Relief for GSK as RSV vaccine clears phase 3 test in adults
GSK will start preparations for regulatory filings of its respiratory syncytial virus (RSV) vaccine straight away, after the shot hit the mark in the much-anticipated AReSVi 006 trial in adults ...
Reuters19d
GSK's RSV, Shingles vaccines show on-par immune response in joint trial
Sept 18 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same ...
imt.ie4d
‘Don’t let RSV hold you back’ says Mary Kennedy as over 65s urged to take proactive steps to stay healthy this winter
Mary Kennedy and GSK Ireland launch Respiratory Syncytial Virus (RSV) awareness campaign encouraging over 65s and at-risk ...